Edition:
United States

Evofem Biosciences Inc (EVFM.OQ)

EVFM.OQ on NASDAQ Stock Exchange Capital Market

2.41USD
16 Jul 2018
Change (% chg)

-- (--)
Prev Close
$2.41
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
12,027
52-wk High
$12.84
52-wk Low
$1.80

Chart for

About

Evofem Biosciences Inc, formerly Neothetics, Inc., is a clinical-stage specialty pharmaceutical company, which develops therapeutics. The Company focuses on localized fat reduction and body contouring. It focuses on the development of LIPO-202 for the reduction of central abdominal bulging due to subcutaneous fat in non-obese... (more)

Overall

Beta: --
Market Cap(Mil.): $6.33
Shares Outstanding(Mil.): 13.83
Dividend: --
Yield (%): --

Financials

  EVFM.OQ Industry Sector
P/E (TTM): -- 30.93 32.76
EPS (TTM): -0.74 -- --
ROI: -80.14 15.07 14.61
ROE: -90.12 16.60 16.34

BRIEF-Evofem Biosciences Announces Pricing Of Public Offering Of Common Stock And Warrants

* EVOFEM BIOSCIENCES ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK AND WARRANTS

May 22 2018

BRIEF-Evofem Biosciences Files For Offering Up To 8 Million Shares Of Co's Stock

* EVOFEM BIOSCIENCES FILES FOR OFFERING UP TO 8 MILLION SHARES OF CO'S STOCK, COMMON WARRANTS TO BUY AGGREGATE OF 1.6 MILLION SHARES OF CO'S COMMON STOCK Source text: (https://bit.ly/2IIfAP7) Further company coverage: (Reuters.Briefs@thomsonreuters.com)

May 16 2018

BRIEF-Evofem Biosciences Receives Fast Track Designation For Amphora For Prevention Of Chlamydia

* EVOFEM BIOSCIENCES RECEIVES FAST TRACK DESIGNATION FOR AMPHORA FOR PREVENTION OF CHLAMYDIA

Feb 21 2018

Earnings vs. Estimates